BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 22566612)

  • 1. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.
    McAfee Q; Zhang Z; Samanta A; Levi SM; Ma XH; Piao S; Lynch JP; Uehara T; Sepulveda AR; Davis LE; Winkler JD; Amaravadi RK
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8253-8. PubMed ID: 22566612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lys05: a new lysosomal autophagy inhibitor.
    Amaravadi RK; Winkler JD
    Autophagy; 2012 Sep; 8(9):1383-4. PubMed ID: 22878685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma.
    Zhou W; Guo Y; Zhang X; Jiang Z
    J Cell Biochem; 2020 Feb; 121(2):2027-2037. PubMed ID: 31642111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroquine, the next generation antimalarial drug, has antitumor activity.
    Kondratskyi A; Kondratska K; Vanden Abeele F; Gordienko D; Dubois C; Toillon RA; Slomianny C; Lemière S; Delcourt P; Dewailly E; Skryma R; Biot C; Prevarskaya N
    Sci Rep; 2017 Nov; 7(1):15896. PubMed ID: 29162859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
    Rebecca VW; Nicastri MC; Fennelly C; Chude CI; Barber-Rotenberg JS; Ronghe A; McAfee Q; McLaughlin NP; Zhang G; Goldman AR; Ojha R; Piao S; Noguera-Ortega E; Martorella A; Alicea GM; Lee JJ; Schuchter LM; Xu X; Herlyn M; Marmorstein R; Gimotty PA; Speicher DW; Winkler JD; Amaravadi RK
    Cancer Discov; 2019 Feb; 9(2):220-229. PubMed ID: 30442709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
    Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.
    Ferreira PMP; Sousa RWR; Ferreira JRO; Militão GCG; Bezerra DP
    Pharmacol Res; 2021 Jun; 168():105582. PubMed ID: 33775862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
    PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Guntuku L; Gangasani JK; Thummuri D; Borkar RM; Manavathi B; Ragampeta S; Vaidya JR; Sistla R; Vegi NGM
    Oncogene; 2019 Jan; 38(4):581-595. PubMed ID: 30166591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
    Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
    Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress of hydroxychloroquine and autophagy inhibitors on cancer.
    Shi TT; Yu XX; Yan LJ; Xiao HT
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):287-294. PubMed ID: 27889812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis.
    Carew JS; Espitia CM; Zhao W; Han Y; Visconte V; Phillips J; Nawrocki ST
    Clin Cancer Res; 2017 Jun; 23(11):2869-2879. PubMed ID: 27881580
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion.
    Mauthe M; Orhon I; Rocchi C; Zhou X; Luhr M; Hijlkema KJ; Coppes RP; Engedal N; Mari M; Reggiori F
    Autophagy; 2018; 14(8):1435-1455. PubMed ID: 29940786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma.
    DeVorkin L; Hattersley M; Kim P; Ries J; Spowart J; Anglesio MS; Levi SM; Huntsman DG; Amaravadi RK; Winkler JD; Tinker AV; Lum JJ
    Mol Cancer Res; 2017 Mar; 15(3):250-258. PubMed ID: 28184014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy.
    Liu LQ; Wang SB; Shao YF; Shi JN; Wang W; Chen WY; Ye ZQ; Jiang JY; Fang QX; Zhang GB; Xuan ZX
    Biomed Pharmacother; 2019 Oct; 118():109339. PubMed ID: 31545270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.
    Piao S; Ojha R; Rebecca VW; Samanta A; Ma XH; Mcafee Q; Nicastri MC; Buckley M; Brown E; Winkler JD; Gimotty PA; Amaravadi RK
    Autophagy; 2017; 13(12):2056-2071. PubMed ID: 28981387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition.
    Jutten B; Keulers TG; Peeters HJM; Schaaf MBE; Savelkouls KGM; Compter I; Clarijs R; Schijns OEMG; Ackermans L; Teernstra OPM; Zonneveld MI; Colaris RME; Dubois L; Vooijs MA; Bussink J; Sotelo J; Theys J; Lammering G; Rouschop KMA
    Autophagy; 2018; 14(2):283-295. PubMed ID: 29377763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
    Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
    Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy.
    Maycotte P; Aryal S; Cummings CT; Thorburn J; Morgan MJ; Thorburn A
    Autophagy; 2012 Feb; 8(2):200-12. PubMed ID: 22252008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.
    Peng X; Zhang S; Jiao W; Zhong Z; Yang Y; Claret FX; Elkabets M; Wang F; Wang R; Zhong Y; Chen ZS; Kong D
    J Exp Clin Cancer Res; 2021 Nov; 40(1):374. PubMed ID: 34844627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.